Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 1.43 Million AUD | 123.64% |
| 2023 | -6.07 Million AUD | -227.79% |
| 2022 | -1.85 Million AUD | -8.26% |
| 2021 | -1.71 Million AUD | -268.44% |
| 2020 | -464.82 Thousand AUD | 81.9% |
| 2019 | -2.56 Million AUD | -24.73% |
| 2018 | -2.05 Million AUD | 10.72% |
| 2017 | -2.3 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 574.31 Thousand AUD | 125.09% |
| 2024 FY | -4.09 Million AUD | 32.7% |
| 2024 Q2 | -2.28 Million AUD | 19.94% |
| 2023 Q4 | -2.85 Million AUD | 11.17% |
| 2023 Q2 | -3.21 Million AUD | -462.71% |
| 2023 FY | -6.07 Million AUD | -227.79% |
| 2022 Q2 | -1.28 Million AUD | 20.84% |
| 2022 FY | -1.85 Million AUD | -8.26% |
| 2022 Q4 | -571.98 Thousand AUD | 55.39% |
| 2021 Q2 | -92.85 Thousand AUD | -116.67% |
| 2021 FY | -1.71 Million AUD | -268.44% |
| 2021 Q4 | -1.61 Million AUD | -1644.44% |
| 2020 FY | -464.82 Thousand AUD | 81.9% |
| 2020 Q4 | 556.83 Thousand AUD | 154.5% |
| 2020 Q2 | -1.02 Million AUD | 6.14% |
| 2019 FY | -2.56 Million AUD | -24.73% |
| 2019 Q4 | -1.08 Million AUD | -7005.25% |
| 2019 Q2 | 15.76 Thousand AUD | 0.0% |
| 2018 FY | -2.05 Million AUD | 10.72% |
| 2017 FY | -2.3 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 59.156% |
| Adherium Limited | -640.83 Thousand AUD | 324.193% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 97.339% |
| Anteris Technologies Ltd | 2.51 Million AUD | 42.924% |
| Control Bionics Limited | 3.67 Million AUD | 60.882% |
| CardieX Limited | 10.1 Million AUD | 85.786% |
| Compumedics Limited | 26.06 Million AUD | 94.489% |
| Cochlear Limited | 1.69 Billion AUD | 99.915% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 87.352% |
| Cyclopharm Limited | 4.49 Million AUD | 68.054% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 87.194% |
| Nova Eye Medical Limited | 20.19 Million AUD | 92.885% |
| HeraMED Limited | -504.09 Thousand AUD | 385.007% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 172.091% |
| ImpediMed Limited | 9 Million AUD | 84.045% |
| InhaleRx Limited | 1.2 Million AUD | -19.323% |
| LBT Innovations Limited | -2.91 Million AUD | 149.253% |
| Micro-X Limited | 5.73 Million AUD | 74.957% |
| Neurotech International Limited | -5867.00 AUD | 24587.898% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -2482.515% |
| PolyNovo Limited | 36.08 Million AUD | 96.019% |
| Respiri Limited | 456.91 Thousand AUD | -214.437% |
| SomnoMed Limited | 55.13 Million AUD | 97.394% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 66.471% |
| Uscom Limited | 3.11 Million AUD | 53.888% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 629.923% |